臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"shih j y"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 496-520 of 1137 (46 Page(s) Totally)
<< < 15 16 17 18 19 20 21 22 23 24 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2020-12-02T02:34:31Z	Modulation of the expression of the invasion-suppressor CRMP-1 by cyclooxygenase-2 inhibition via reciprocal regulation of Sp1 and C/EBPα	Wu C.-C.; Lin J.-C.; Yang S.-C.; Lin C.-W.; Chen J.J.W.; Shih J.-Y.; Hong T.-M.; Pan-Chyr Yang; Wu C.-C.; Lin J.-C.; Yang S.-C.; Lin C.-W.; Chen J.J.W.; Shih J.-Y.; Hong T.-M.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:31Z	First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer	Wu J.-Y.; Yu C.-J.; Yang C.-H.; Wu S.-G.; Chiu Y.-H.; Gow C.-H.; Chang Y.-C.; Hsu Y.-C.; Wei P.-F.; Shih J.-Y.; Pan-Chyr Yang; Wu J.-Y.; Yu C.-J.; Yang C.-H.; Wu S.-G.; Chiu Y.-H.; Gow C.-H.; Chang Y.-C.; Hsu Y.-C.; Wei P.-F.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:30Z	Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial	Hsu C.; Kuo S.-H.; Hu F.-C.; Cheng A.-L.; Shih J.-Y.; Yu C.-J.; Lin C.-C.; Huang T.-C.; PAN-CHYR YANG; Yang C.-H.
臺大學術典藏	2020-12-02T02:34:29Z	Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern	Wu S.-G.; Chang Y.-L.; Hsu Y.-C.; Wu J.-Y.; Yang C.-H.; Yu C.-J.; Tsai M.-F.; Shih J.-Y.; Pan-Chyr Yang; Wu S.-G.; Chang Y.-L.; Hsu Y.-C.; Wu J.-Y.; Yang C.-H.; Yu C.-J.; Tsai M.-F.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:27Z	Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer	Gow C.-H.; Chang Y.-L.; Hsu Y.-C.; Tsai M.-F.; Wu C.-T.; Yu C.-J.; Yang C.-H.; Lee Y.-C.; Pan-Chyr Yang; Shih J.-Y.; Gow C.-H.; Chang Y.-L.; Hsu Y.-C.; Tsai M.-F.; Wu C.-T.; Yu C.-J.; Yang C.-H.; Lee Y.-C.; PAN-CHYR YANG; Shih J.-Y.
臺大學術典藏	2020-12-02T02:34:25Z	EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment	Huang C.-L.; Yang C.-H.; Yeh K.-H.; Hu F.-C.; Chen K.-Y.; Shih J.-Y.; Lin Z.-Z.; Yu C.-J.; Cheng A.-L.; Pan-Chyr Yang; Huang C.-L.; Yang C.-H.; Yeh K.-H.; Hu F.-C.; Chen K.-Y.; Shih J.-Y.; Lin Z.-Z.; Yu C.-J.; Cheng A.-L.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:22Z	From midbody protein - Protein interaction network construction to novel regulators in cytokinesis	Chen T.-C.; Lee S.-A.; Hong T.-M.; Shih J.-Y.; Lai J.-M.; Chiou H.-Y.; Yang S.-C.; Chan C.-H.; Kao C.-Y.; Pan-Chyr Yang; Huang C.-Y.F.; Chen T.-C.; PAN-CHYR YANG et al.
臺大學術典藏	2020-12-02T02:34:20Z	Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer	Wu J.-Y.;Shih J.-Y.;Yang C.-H.;Chen K.-Y.;Ho C.-C.;Yu C.-J.;Pan-Chyr Yang; Wu J.-Y.; Shih J.-Y.; Yang C.-H.; Chen K.-Y.; Ho C.-C.; Yu C.-J.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:19Z	Octogenarians with advanced non-small cell lung cancer: Treatment modalities, survival, and prognostic factors	Chen K.-Y.;Chen J.-H.;Shih J.-Y.;Yang C.-H.;Yu C.-J.;Pan-Chyr Yang; Chen K.-Y.; Chen J.-H.; Shih J.-Y.; Yang C.-H.; Yu C.-J.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:18Z	Influence of first-line chemotherapy and EGFR mutations on second-line gefitinib in advanced non-small cell lung cancer	Wu J.-Y.;Yu C.-J.;Shih J.-Y.;Yang C.-H.;Pan-Chyr Yang; Wu J.-Y.; Yu C.-J.; Shih J.-Y.; Yang C.-H.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:18Z	Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma	Huang C.-T.;Yen R.-F.;Cheng M.-F.;Hsu Y.-C.;Wei P.-F.;Tsai Y.-J.;Tsai M.-F.;Shih J.-Y.;Yang C.-H.;Pan-Chyr Yang; Huang C.-T.; Yen R.-F.; Cheng M.-F.; Hsu Y.-C.; Wei P.-F.; Tsai Y.-J.; Tsai M.-F.; Shih J.-Y.; Yang C.-H.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:17Z	Use of cetuximab after failure of gefitinib in patients with advanced non-small-cell lung cancer	Wu J.-Y.;Yang C.-H.;Hsu Y.-C.;Yu C.-J.;Chang S.-H.;Shih J.-Y.;Pan-Chyr Yang; Wu J.-Y.; Yang C.-H.; Hsu Y.-C.; Yu C.-J.; Chang S.-H.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:15Z	Identification of a novel biomarker, SEMA5A, for non-small cell lung carcinoma in nonsmoking women	Lu T.-P.;Tsai M.-H.;Lee J.-M.;Hsu C.-P.;Chen P.-C.;Lin C.-W.;Shih J.-Y.;Pan-Chyr Yang;Hsiao C.K.;Lai L.-C.;Chuang E.Y.; Lu T.-P.; Tsai M.-H.; Lee J.-M.; Hsu C.-P.; Chen P.-C.; Lin C.-W.; Shih J.-Y.; PAN-CHYR YANG; Hsiao C.K.; Lai L.-C.; Chuang E.Y.
臺大學術典藏	2020-12-02T02:34:13Z	Epidermal growth factor receptor mutations in small cell lung cancer: A brief report	Shiao T.-H. ;Chang Y.-L. ;Yu C.-J. ;Chang Y.-C. ;Hsu Y.-C. ;Chang S.-H. ;Shih J.-Y. ;Pan-Chyr Yang; Shiao T.-H.; Chang Y.-L.; Yu C.-J.; Chang Y.-C.; Hsu Y.-C.; Chang S.-H.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:12Z	The prognostic value of the simplified comorbidity score in the treatment of small cell lung carcinoma	Kuo Y.-W. ;Jerng J.-S. ;Shih J.-Y. ;Chen K.-Y. ;Yu C.-J. ;Pan-Chyr Yang; Kuo Y.-W.; Jerng J.-S.; Shih J.-Y.; Chen K.-Y.; Yu C.-J.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:10Z	Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations	Wu J.-Y.;Wu S.-G.;Yang C.-H.;Chang Y.-L.;Chang Y.-C.;Hsu Y.-C.;Shih J.-Y.;Pan-Chyr Yang; Wu J.-Y.; Wu S.-G.; Yang C.-H.; Chang Y.-L.; Chang Y.-C.; Hsu Y.-C.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:10Z	Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations	Wu J.-Y.; Shih J.-Y.; Chen K.-Y.; Yang C.-H.; Yu C.-J.; Pan-Chyr Yang; Wu J.-Y.; Shih J.-Y.; Chen K.-Y.; Yang C.-H.; Yu C.-J.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:09Z	Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer	Wu J.-Y.;Yu C.-J.;Chang Y.-C.;Yang C.-H.;Shih J.-Y.;Pan-Chyr Yang; Wu J.-Y.; Yu C.-J.; Chang Y.-C.; Yang C.-H.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:09Z	Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations	Wu S.-G.; Yang C.-H.; Yu C.-J.; Lee J.-H.; Hsu Y.-C.; Chang Y.-L.; Shih J.-Y.; Pan-Chyr Yang; Wu S.-G.; Yang C.-H.; Yu C.-J.; Lee J.-H.; Hsu Y.-C.; Chang Y.-L.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:06Z	The EMT regulator slug and lung carcinogenesis	Shih J.-Y.;Pan-Chyr Yang; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:05Z	Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: The association with treatment efficacy of pemetrexed	Chen C.-Y.; Chang Y.-L.; Shih J.-Y.; Lin J.-W.; Chen K.-Y.; Yang C.-H.; Yu C.-J.; Pan-Chyr Yang; Chen C.-Y.; Chang Y.-L.; Shih J.-Y.; Lin J.-W.; Chen K.-Y.; Yang C.-H.; Yu C.-J.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:04Z	Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma	Tsai T.-H.; Wu S.-G.; Chang Y.-L.; Wu C.-T.; Tsai M.-F.; Wei P.-F.; Yang C.-H.; Yu C.-J.; PAN-CHYR YANG; Shih J.-Y.
臺大學術典藏	2020-12-02T02:34:04Z	Percutaneous computed tomography-guided coaxial core biopsy for small pulmonary lesions with ground-glass attenuation	Lu C.-H.; Hsiao C.-H.; Chang Y.-C.; Lee J.-M.; Shih J.-Y.; Wu L.-A.; Yu C.-J.; Liu H.-M.; Shih T.T.-F.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:03Z	Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancer	Su K.-Y.; Chen H.-Y.; Li K.-C.; Kuo M.-L.; Yang J.C.-H.; Chan W.-K.; Ho B.-C.; Chang G.-C.; Shih J.-Y.; Yu S.-L.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:03Z	Clinical significance of thyroid transcription factor-1 in advanced lung adenocarcinoma under epidermal growth factor receptor tyrosine kinase inhibitor treatment	Chung K.-P.; Huang Y.-T.; Chang Y.-L.; Yu C.-J.; Yang C.-H.; Chang Y.-C.; Shih J.-Y.; PAN-CHYR YANG

Showing items 496-520 of 1137 (46 Page(s) Totally)
<< < 15 16 17 18 19 20 21 22 23 24 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 2826208
	???header.visitor??? : 31908119 ???header.onlineuser??? : 1373 ???header.sponsordeclaration???